Results 301 to 310 of about 3,187,926 (385)

NIR II‐Guided Photoactivatable Silencing Polyplex Boosts Cancer Immunotherapy

open access: yesExploration, EarlyView.
Due to limitation of penetration therapy with first and second‐generation photodynamic therapy (PDT) photosensitizers, an NIR II‐guided photoactivatable complex was proposed via the self‐assembly of the photosensitive polymer PTSQ and the electrostatic adsorption of siPD‐L1 to enhance cancer immunotherapy.
Yuquan Zhang   +10 more
wiley   +1 more source

Endovascular Embolization in Acquired Hemophilia A: A Case Study Highlighting Diagnostic and Therapeutic Strategies. [PDF]

open access: yesAm J Case Rep
Makris M   +7 more
europepmc   +1 more source

Atrial cardiomyopathy

open access: yes
ESC Heart Failure, Volume 12, Issue 2, Page 727-729, April 2025.
Wojciech Kosmala   +1 more
wiley   +1 more source

An Intrahepatic Cholangiocarcinoma Patient with von Willebrand Disease Successfully Treated with Robotic Hepatectomy under von Willebrand Factor Supplementation. [PDF]

open access: yesSurg Case Rep
Chiba H   +12 more
europepmc   +1 more source

Disorders of Coagulation

Urologic Clinics of North America, 1983
The routine preoperative performance of a platelet count, bleeding time, prothrombin time, and partial thromboplastin time will reveal most of the major inherited or acquired bleeding diatheses that are likely to be troublesome during or after an operation.
Bowie Ej, Owen Ca
openaire   +3 more sources

Abnormal factor X (factor X Friuli) coagulation disorder. The heterozygote population. A study of 57 subjects.

Acta Haematologica, 1974
Data are reported pertaining to the 57 subjects so far found to be heterozygotes for the abnormal factor X (factor X Friuli) coagulation disorder.
A. Girolami   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy